Johnson & Johnson JNJ
NYSE JNJ
$275.46 +3.14 (+1.15%)
As of: Nov 6, 2026 · 2:57 PM EST

Johnson & Johnson (JNJ) Non Operating Interest Expenses (2009 - 2026)

Updated

Johnson & Johnson's Non Operating Interest Expenses was $217 million in Q3 2026, down 11.4% from $245 million a year earlier and down 22.8% from the prior quarter.

Analysis

Johnson & Johnson (JNJ) Non Operating Interest Expenses (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Johnson & Johnson's Non Operating Interest Expenses was $984 million through Sep 27, 2026, up 10.1% year-over-year; for FY2025, it came in at $971 million, up 28.6% from FY2024.

  • Non Operating Interest Expenses shows a four-year compound annual growth rate of 48.3% (FY2021 to FY2025).
  • In earlier years, Non Operating Interest Expenses was $755 million in FY2024 (-2.2%), $772 million in FY2023 (+179.7%), $276 million in FY2022 and $201 million in FY2021.
  • Quarterly Non Operating Interest Expenses has moved between $137 million (Q4 2024) and $308 million (Q2 2025) over five years.
  • Compared with a year earlier, Non Operating Interest Expenses was higher in five of the last eight quarters, with growth averaging 16.6%.
  • The best year-over-year quarter for Non Operating Interest Expenses over five years was Q4 2025 (growth of 56.2%); the worst was Q1 2024 (a decline of 26.9%).
  • Per Business Quant data, JNJ's Non Operating Interest Expenses in the three quarters before Q3 2026 was $281 million (Q2 2026), $272 million (Q1 2026) and $214 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,214.11 Bn 1,187.72 Bn 20.46 Bn -
2 Johnson & Johnson 663.75 Bn 583.61 Bn 17.30 Bn 217.00 Mn
3 AbbVie 513.52 Bn 481.53 Bn 13.12 Bn -
4 Merck 362.02 Bn 324.96 Bn 13.19 Bn -
5 Novartis Ag 314.18 Bn 287.41 Bn - -
6 Astrazeneca 288.03 Bn 261.92 Bn 13.26 Bn -477.00 Mn
7 Amgen 249.76 Bn 201.41 Bn 7.58 Bn 653.00 Mn
8 Gilead Sciences 208.51 Bn 183.62 Bn 6.73 Bn 269.00 Mn
9 Pfizer 167.24 Bn 114.60 Bn 12.56 Bn -
10 Vertex Pharmaceuticals 138.71 Bn 110.70 Bn 2.91 Bn 36.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 27, 2026 217.00 Mn
Jun 28, 2026 281.00 Mn
Mar 29, 2026 272.00 Mn
Dec 28, 2025 214.00 Mn
Sep 28, 2025 245.00 Mn
Jun 29, 2025 308.00 Mn
Mar 30, 2025 204.00 Mn
Dec 29, 2024 137.00 Mn
Sep 29, 2024 193.00 Mn
Jun 30, 2024 270.00 Mn
Mar 31, 2024 155.00 Mn
Dec 31, 2023 151.00 Mn
Oct 1, 2023 192.00 Mn
Jul 2, 2023 217.00 Mn
Apr 2, 2023 212.00 Mn
Jan 1, 2023 153.00 Mn
Oct 2, 2022 51.00 Mn
Jul 3, 2022 38.00 Mn
Apr 3, 2022 10.00 Mn
Oct 3, 2021 20.00 Mn
API Access

Johnson & Johnson Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=JNJ&period=max&api_key=YOUR_API_KEY